Biomarkers towards Ovarian Cancer Diagnostics: Present and Future Prospects

AUTOR(ES)

Rastogi, Meenal, Gupta, Sameer, Sachan, Manisha

FONTE

Braz. arch. biol. technol.

DATA DE PUBLICAÇÃO

31/10/2016

RESUMO

ABSTRACT Ovarian carcinoma accounts for highest mortality of all gynecologic malignancies as the disease is asymptomatic until late stages. Biomarkers such as CA-125 and HE4 are being currently used for diagnosis of ovarian cancer, but they show contradicting diagnostic accuracy. Therefore other biomarkers have been investigated for early detection of this disease, but no success has been obtained and no test has yet been recommended for screening a general population. In this instance, aptamers can be effectively used to identify tumor-specific antigens for early diagnosis and targeted therapy of ovarian cancer. This article provides an overview of the biomarkers/panels being explored as well as the potential of aptamers to improve current long-term survival rates of ovarian cancer.

Documentos Relacionados

• International Medical Documentation Present Status and Future Prospects *
• Lung cancer: Current Status and Prospects for the Future
• Towards an integrated proteomic and glycomic approach to finding cancer biomarkers
• Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions
• Eigenvalue based inverse model of beam for structural modification and diagnostics: theoretical formulation